BE728559A - - Google Patents

Info

Publication number
BE728559A
BE728559A BE728559DA BE728559A BE 728559 A BE728559 A BE 728559A BE 728559D A BE728559D A BE 728559DA BE 728559 A BE728559 A BE 728559A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE728559A publication Critical patent/BE728559A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE728559D 1968-02-19 1969-02-17 BE728559A (US07709020-20100504-C00041.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70664968A 1968-02-19 1968-02-19

Publications (1)

Publication Number Publication Date
BE728559A true BE728559A (US07709020-20100504-C00041.png) 1969-08-18

Family

ID=24838493

Family Applications (1)

Application Number Title Priority Date Filing Date
BE728559D BE728559A (US07709020-20100504-C00041.png) 1968-02-19 1969-02-17

Country Status (10)

Country Link
US (1) US3487155A (US07709020-20100504-C00041.png)
BE (1) BE728559A (US07709020-20100504-C00041.png)
CH (1) CH501608A (US07709020-20100504-C00041.png)
DE (1) DE1907330A1 (US07709020-20100504-C00041.png)
DK (1) DK123232B (US07709020-20100504-C00041.png)
FR (1) FR2002160A1 (US07709020-20100504-C00041.png)
GB (1) GB1256803A (US07709020-20100504-C00041.png)
IL (1) IL31639A0 (US07709020-20100504-C00041.png)
NL (1) NL6902423A (US07709020-20100504-C00041.png)
SE (1) SE350489B (US07709020-20100504-C00041.png)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1427141A (en) * 1972-05-03 1976-03-10 Bdh Pharmaceuticals Ltd 17-alka-1,3-diynyl- steroids
US6908910B2 (en) 1993-08-06 2005-06-21 The Children's Medical Center Corporation Estrogenic compounds as anti-mitotic agents
US5504074A (en) 1993-08-06 1996-04-02 Children's Medical Center Corporation Estrogenic compounds as anti-angiogenic agents
EP1124545B1 (en) 1998-08-11 2004-12-15 EntreMed, Inc. Use of 2-methoxyestradiol as anti-fungal agents
US7087592B1 (en) 1999-08-23 2006-08-08 Entre Med, Inc. Compositions comprising purified 2-methoxyestradiol and methods of producing same
US6995278B2 (en) 2000-08-18 2006-02-07 Entre Med, Inc. Antiangiogenic agents
US7135581B2 (en) 2000-08-18 2006-11-14 Entremed, Inc. Antiangiogenic agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE564226A (US07709020-20100504-C00041.png) *
FR1327004A (fr) * 1958-05-20 1963-05-17 British Drug Houses Ltd Procédé de fabrication de 17beta-hydroxy-17alpha-alkynyl-stéroïdes de l'androstane et du 3,5-cyclo-androstane
BE641351A (US07709020-20100504-C00041.png) * 1962-12-19
NL128376C (US07709020-20100504-C00041.png) * 1964-04-23

Also Published As

Publication number Publication date
SE350489B (US07709020-20100504-C00041.png) 1972-10-30
GB1256803A (US07709020-20100504-C00041.png) 1971-12-15
CH501608A (de) 1971-01-15
DK123232B (da) 1972-05-29
FR2002160A1 (US07709020-20100504-C00041.png) 1969-10-17
IL31639A0 (en) 1969-04-30
NL6902423A (US07709020-20100504-C00041.png) 1969-08-21
US3487155A (en) 1969-12-30
DE1907330A1 (de) 1969-10-23

Similar Documents

Publication Publication Date Title
AU428130B2 (US07709020-20100504-C00041.png)
AU2374870A (US07709020-20100504-C00041.png)
AU5184069A (US07709020-20100504-C00041.png)
AU6168869A (US07709020-20100504-C00041.png)
FR2002160A1 (US07709020-20100504-C00041.png)
AU6171569A (US07709020-20100504-C00041.png)
AU429879B2 (US07709020-20100504-C00041.png)
AU416157B2 (US07709020-20100504-C00041.png)
AU2581067A (US07709020-20100504-C00041.png)
AU421558B1 (US07709020-20100504-C00041.png)
AU3789668A (US07709020-20100504-C00041.png)
AU4744468A (US07709020-20100504-C00041.png)
AU3224368A (US07709020-20100504-C00041.png)
AU2580267A (US07709020-20100504-C00041.png)
AU479894A (US07709020-20100504-C00041.png)
AU5758767A (US07709020-20100504-C00041.png)
BE630165A (US07709020-20100504-C00041.png)
BE642636A (US07709020-20100504-C00041.png)
BE723144A (US07709020-20100504-C00041.png)
BE708888A (US07709020-20100504-C00041.png)
AU479393A (US07709020-20100504-C00041.png)
BE708951A (US07709020-20100504-C00041.png)
AU463027A (US07709020-20100504-C00041.png)
AU4558658A (US07709020-20100504-C00041.png)
AU4503667A (US07709020-20100504-C00041.png)